WO2014155268A2 - Fgf-r tyrosine kinase activity inhibitors - use in diseases associated with lack of or reduced snf5 activity - Google Patents

Fgf-r tyrosine kinase activity inhibitors - use in diseases associated with lack of or reduced snf5 activity Download PDF

Info

Publication number
WO2014155268A2
WO2014155268A2 PCT/IB2014/060087 IB2014060087W WO2014155268A2 WO 2014155268 A2 WO2014155268 A2 WO 2014155268A2 IB 2014060087 W IB2014060087 W IB 2014060087W WO 2014155268 A2 WO2014155268 A2 WO 2014155268A2
Authority
WO
WIPO (PCT)
Prior art keywords
snf5
activity
fgfr
fgfr inhibitor
treatment
Prior art date
Application number
PCT/IB2014/060087
Other languages
French (fr)
Other versions
WO2014155268A3 (en
Inventor
Diana Graus Porta
Simon Woehrle
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to US201361804797P priority Critical
Priority to US61/804,797 priority
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of WO2014155268A2 publication Critical patent/WO2014155268A2/en
Publication of WO2014155268A3 publication Critical patent/WO2014155268A3/en

Links